Universal DX is a Spanish startup developing cutting-edge blood-based liquid biopsy solutions for the early detection of cancer.
The financing is part of the support the EIB is providing to European MedTech startups developing innovative medical solutions and contributes to the EIB Group strategic priority of accelerating digitalisation and technological innovation.
The operation is supported by InvestEU, an EU programme that aims to unlock over €372 billion in investment by 2027.
